IL6 and Alzheimer disease: In contrast, Schuitemaker et al. [33] have reported that serum IL-6 level was significantly higher in MCI, which suggested that inflammatory processes might be involved in early stages of AD, and different inflammatory markers might play major roles in certain developing stages of cognition decline.